Cosmos Health Inc./$COSM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
Ticker
$COSM
Sector
Trading on
Industry
Health Care Providers & Services
Headquarters
Employees
149
ISIN
US2214133058
Website
COSM Metrics
BasicAdvanced
$13M
-
-$0.99
4.30
-
Price and volume
Market cap
$13M
Beta
4.3
52-week high
$0.59
52-week low
$0.28
Average daily volume
679K
Financial strength
Current ratio
1.047
Quick ratio
0.638
Long term debt to equity
9.854
Total debt to equity
49.512
Interest coverage (TTM)
-13.82%
Management effectiveness
Return on assets (TTM)
-14.90%
Return on equity (TTM)
-50.03%
Valuation
Price to revenue (TTM)
0.184
Price to book
0.48
Price to tangible book (TTM)
0.69
Price to free cash flow (TTM)
-1.729
Growth
Revenue change (TTM)
-3.70%
Earnings per share change (TTM)
-50.51%
3-year revenue growth (CAGR)
-2.45%
3-year earnings per share growth (CAGR)
-67.08%
COSM News
AllArticlesVideos
RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven
GlobeNewsWire·3 weeks ago
Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units
GlobeNewsWire·4 weeks ago
Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cosmos Health Inc. stock?
Cosmos Health Inc. (COSM) has a market cap of $13M as of June 03, 2025.
What is the P/E ratio for Cosmos Health Inc. stock?
The price to earnings (P/E) ratio for Cosmos Health Inc. (COSM) stock is 0 as of June 03, 2025.
Does Cosmos Health Inc. stock pay dividends?
No, Cosmos Health Inc. (COSM) stock does not pay dividends to its shareholders as of June 03, 2025.
When is the next Cosmos Health Inc. dividend payment date?
Cosmos Health Inc. (COSM) stock does not pay dividends to its shareholders.
What is the beta indicator for Cosmos Health Inc.?
Cosmos Health Inc. (COSM) has a beta rating of 4.3. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.